TechCrunch AI
·
3 days ago
Databricks raised funding at a $188 billion valuation, led by Coatue, with approximately $3 billion expected to close later this summer. The company raised $134 billion just five months prior in February, and has completed four major funding rounds totaling over $17 billion since December 2024. Databricks shifted from a data analytics company to an AI provider by launching products like Lakebase and Unity, positioning itself to capitalize on enterprise demand for AI with traditional software governance standards.
OpenAI Blog
·
4 days ago
● 2 sources
OpenAI's CFO Sarah Friar presented a framework to measure AI return on investment using metrics like useful work completed, cost per successful task, dependability, and return on compute. The scorecard provides four specific dimensions for evaluating AI system performance beyond traditional efficiency measures. Organizations can now apply these metrics to assess whether their AI implementations are delivering business value relative to computational resources invested.
Tech.eu
·
4 days ago
SAP acquired German AI company Prior Labs for over €1 billion, just 18 months after its founding. Prior Labs developed TabPFN, a tabular foundation model capable of handling enterprise prediction tasks like payment delays and demand forecasting without requiring separate models for each dataset. The acquisition provides Prior Labs with resources and access to SAP's enterprise data ecosystem to pursue multi-year frontier research in areas including causality, relational data, and scientific applications while maintaining its independent brand and research agenda.
Tech.eu
·
4 days ago
Sightera Biosciences, a Belgian techbio company, raised €3 million in pre-seed funding to expand its generative AI platform for discovering small-molecule drugs trained on patient-derived biological samples. The company uses proprietary datasets from patient organoids and disease models to train AI that designs drug candidates based on actual human disease biology rather than chemical properties alone. The funding will accelerate development of its oncology and fibrosis pipeline and support expansion of partnerships and team growth.
